Successful treatment of dermatomyositis with low-dose naltrexone (Abstract)

The LDN 2021 Conference Recordings Now Available with up to 29 CME Credits [More Details]

Medical Professionals Become an LDN Specialist [More Details]

Successful treatment of dermatomyositis with low-dose naltrexone

Dermatol Ther
25 September 2018
https://www.deepdyve.com/lp/wiley/successful-treatment-of-dermatomyositis-with-low-dose-naltrexone-Tb0k99n0nE

Low-dose naltrexone has been shown to treat autoimmune conditions, such as multiple sclerosis, fibromyalgia, and Crohn's disease. We present two cases in which low-dose naltrexone proved an effective therapy for dermatomyositis (DM), an idiopathic inflammatory myopathy. Low-dose naltrexone as treatment for DM is promising, as the cost of the medication is low, and its adverse effects are minimal